Overview
Availability
- Associate Professor Simone M Goldinger is:
- Available for supervision
Qualifications
- Bachelor (Honours) of Medicine, University of Zurich
- Masters (Research) of Medicine and Surgery and Medical Science, University of Zurich
- Doctoral (Research), University of Zurich
- Professional Doctorate, University of Zurich
- Fellow, Australasian College of Dermatologists, Australasian College of Dermatologists
Works
Search Professor Simone M Goldinger’s works on UQ eSpace
2017
Conference Publication
Thin melanoma in Swiss Patients: A clinicopathological comparison
Kaufmann, C., Mangana, J., Cheng, P., Ramelyte, E., Goldinger, S. M., Levesque, M. P. and Dummer, R. (2017). Thin melanoma in Swiss Patients: A clinicopathological comparison. HOBOKEN: WILEY.
2017
Conference Publication
The peripheral blood TCR repertoire might facilitate patient stratification for immune checkpoint blockade inhibition in metastatic melanoma
Schindler, S., Courtier, A., Jaberg-Bentele, N., Goldinger, S., Manuel, M., Perez, S., Mouret, J. -F., Nguyen-Kim, T. D. L., Raaijmakers, M., Kvistborg, P., Pasqua, N., Haanen, J., Dummer, R. and Levesque, M. (2017). The peripheral blood TCR repertoire might facilitate patient stratification for immune checkpoint blockade inhibition in metastatic melanoma. HOBOKEN: WILEY.
2017
Journal Article
Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?
Haueis, Silvia A., Kranzlin, Pascale, Mangana, Joanna, Cheng, Phil F., Urosevic-Maiwald, Mirjana, Braun, Ralph P., Levesque, Mitchell P., Dummer, Reinhard and Goldinger, Simone M. (2017). Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?. Melanoma Research, 27 (3), 231-237. doi: 10.1097/CMR.0000000000000338
2017
Journal Article
Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma
Bossart, Simon, Thurneysen, Selina, Rushing, Elisabeth, Frontzek, Karl, Leske, Henning, Mihic-Probst, Daniela, Nagel, Hannes W., Mangana, Johanna, Goldinger, Simone M. and Dummer, Reinhard (2017). Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma. Oncologist, 22 (6), 749-753. doi: 10.1634/theoncologist.2016-0366
2017
Conference Publication
Sarcoid-like reactions under modern melanoma treatment
Dimitriou, F., Frauchiger, A., Goldinger, S. M., Braun, R., Mangana, J. and Dummer, R. (2017). Sarcoid-like reactions under modern melanoma treatment. HOBOKEN: WILEY.
2017
Conference Publication
Re-challenge with BRAF-directed treatment: A multi-institutional retrospective study
Valpione, Sara, Carlino, Matteo S., Mangana, Joanna, Mooradian, Meghan, McArthur, Grant A., Schadendorf, Dirk, Hauschild, Axel, Long, Georgina V., Arance, Ana M., Ascierto, Paolo Antonio, Maio, Michele, De Rosa, Francesco, Larkin, James M. G., Park, John J., Goldinger, Simone M., Flaherty, Keith, Xu, Wen, Livingstone, Elisabeth, Weichenthal, Michael and Lorigan, Paul (2017). Re-challenge with BRAF-directed treatment: A multi-institutional retrospective study. 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.9512
2017
Conference Publication
Incidence, features and management of radionecrosis (RN) in melanoma patients (pts) treated with cerebral radiotherapy (RT) and anti-PD-1 antibodies (PD1)
da Silva, Ines Esteves Domingues Pires, Johnpulle, Romany Anne Nilanthi, Banks, Patricia Diana, Grass, G. Daniel, Smith, Jess Louise, Everett, Ashlyn S., Goldinger, Simone M., -Thomson, Rachel Roberts, Millward, Michael, Glitza, Isabella Claudia, Haydu, Lauren Elaine, Atkinson, Victoria, Wang, Tim, Eroglu, Zeynep, Conry, Robert Martin, Shackleton, Mark J., Hong, Angela, Long, Georgina V., Johnson, Douglas Buckner and Menzies, Alexander M. (2017). Incidence, features and management of radionecrosis (RN) in melanoma patients (pts) treated with cerebral radiotherapy (RT) and anti-PD-1 antibodies (PD1). 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.9513
2017
Conference Publication
Hyperproliferative keratinocytic cutaneous adverse events and inflammatory palmoplantar erythrodysesthesia in melanoma patients treated with encorafenib compared to other BRAF inhibitors
Goldinger, Simone M., Graf, Natalie P., Galliker, Nadja, Conrad, Samuel and Dummer, Reinhard (2017). Hyperproliferative keratinocytic cutaneous adverse events and inflammatory palmoplantar erythrodysesthesia in melanoma patients treated with encorafenib compared to other BRAF inhibitors. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.9590
2017
Journal Article
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
Kaufmann, Fabrice and Goldinger, Simone M. (2017). Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma. International Journal of Radiation Oncology Biology Physics, 98 (1), 15-16. doi: 10.1016/j.ijrobp.2017.01.245
2017
Journal Article
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Tumeh, Paul C., Hellmann, Matthew D., Hamid, Omid, Tsai, Katy K., Loo, Kimberly L., Gubens, Matthew A., Rosenblum, Michael, Harview, Christina L., Taube, Janis M., Handley, Nathan, Khurana, Neharika, Nosrati, Adi, Krummel, Matthew F., Tucker, Andrew, Sosa, Eduardo V., Sanchez, Phillip J., Banayan, Nooriel, Osorio, Juan C., Nguyen-Kim, Dan L., Chang, Jeremy, Shintaku, I. Peter, Boasberg, Peter D., Taylor, Emma J., Munster, Pamela N., Algazi, Alain P., Chmielowski, Bartosz, Dummer, Reinhard, Grogan, Tristan R., Elashoff, David ... Daud, Adil (2017). Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC. Cancer Immunology Research, 5 (5), 417-424. doi: 10.1158/2326-6066.CIR-16-0325
2017
Journal Article
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy
Nosrati, Adi, Tsai, Katy K., Goldinger, Simone M., Tumeh, Paul, Grimes, Barbara, Loo, Kimberly, Algazi, Alain P., Thi Dan Linh Nguyen-Kim, , Levesque, Mitchell, Dummer, Reinhard, Hamid, Omid and Daud, Adil (2017). Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. British Journal of Cancer, 116 (9), 1141-1147. doi: 10.1038/bjc.2017.70
2017
Journal Article
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Zimmer, Lisa, Apuri, Susmitha, Eroglu, Zeynep, Kottschade, Lisa A., Forschner, Andrea, Gutzmer, Ralf, Schlaak, Max, Heinzerling, Lucie, Krackhardt, Angela M., Loquai, Carmen, Markovic, Svetomir N., Joseph, Richard W., Markey, Kelly, Utikal, Jochen S., Weishaupt, Carsten, Goldinger, Simone M., Sondak, Vernon K., Zager, Jonathan S., Schadendorf, Dirk and Khushalani, Nikhil I. (2017). Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. European Journal of Cancer, 75, 47-55. doi: 10.1016/j.ejca.2017.01.009
2017
Journal Article
Critical aspects to achieve a high-quality melanoma clinic
Dummer, Reinhard, Ramelyte, Egle, Levesque, Mitch, Goldinger, Simone M. and Braun, Ralph P. (2017). Critical aspects to achieve a high-quality melanoma clinic. Current Opinion in Oncology, 29 (2), 145-150. doi: 10.1097/CCO.0000000000000357
2017
Journal Article
A review of serious adverse effects under treatment with checkpoint inhibitors
Heinzerling, Lucie and Goldinger, Simone M. (2017). A review of serious adverse effects under treatment with checkpoint inhibitors. Current Opinion in Oncology, 29 (2), 136-144. doi: 10.1097/CCO.0000000000000358
2017
Journal Article
Developments in targeted therapy in melanoma
Amann, V. C., Ramelyte, E., Thurneysen, S., Pitocco, R., Bentele-Jaberg, N., Goldinger, S. M., Dummer, R. and Mangana, J. (2017). Developments in targeted therapy in melanoma. Ejso, 43 (3), 581-593. doi: 10.1016/j.ejso.2016.10.014
2016
Journal Article
Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?
Diem, Stefan, Keller, Fabienne, Ruesch, Reinhard, Maillard, Samia A., Speiser, Daniel E., Dummer, Reinhard, Siano, Marco, Urner-Bloch, Ursula, Goldinger, Simone M. and Flatz, Lukas (2016). Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?. Journal of Immunotherapy, 39 (9), 379-382. doi: 10.1097/CJI.0000000000000143
2016
Journal Article
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel
Thurneysen, S., Cheng, P. F., Nagel, H. W., Kunz, M., Jaberg-Bentele, N., Nageli, M., Ziegler, M., Guenova, E., Goldinger, S. M., Mangana, J., Levesque, M. P. and Dummer, R. (2016). An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. British Journal of Dermatology, 175 (5), 966-978. doi: 10.1111/bjd.14727
2016
Conference Publication
A phase I, open-label study of pasireotide in patients with BRAF-and NRAS-wild type, unresectable and or metastatic melanoma
Dummer, R., Michielin, O. A., Nageli, M., Goldinger, S. M., Campigotto, F., Kriemler-Krahn, U., Schmid, H., Pedroncelli, A., Micaletto, S. and Schadendorf, D. (2016). A phase I, open-label study of pasireotide in patients with BRAF-and NRAS-wild type, unresectable and or metastatic melanoma. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/annonc/mdw379.43
2016
Conference Publication
Systemic treatment influences on immune accessibility of melanoma: A retrospective histopathological investigation
Krahenbuhl, L., Goldinger, S. M., Kerl, K., Kempf, W., Chevolet, I., Brochez, L., Cheng, P., Mangana, J., Levesque, M. P. and Dummer, R. (2016). Systemic treatment influences on immune accessibility of melanoma: A retrospective histopathological investigation. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/annonc/mdw379.28
2016
Journal Article
MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects
Urner-Bloch, U., Urner, M., Jaberg-Bentele, N., Frauchiger, A. L., Dummer, R. and Goldinger, S. M. (2016). MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects. European Journal of Cancer, 65, 130-138. doi: 10.1016/j.ejca.2016.06.018
Supervision
Availability
- Associate Professor Simone M Goldinger is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Associate Professor Simone M Goldinger's areas of expertise, story ideas and help finding experts, contact our Media team: